MedTrace Logo

Safety and Tolerability of BioFe for Iron Deficiency Management

NCT03484026 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2020-07-02

No results posted yet for this study

Summary

This study evaluates the safety, tolerability, and activity of BioFe in the dietary management of iron deficiency in adults.

Conditions

Interventions

DIETARY_SUPPLEMENT

BioFe

BioFe Medical Food is comprised of cultured nutritional/Baker's yeast (Saccharomyces cerevisiae) with high levels of Ferritin/Iron complex, pasteurized, and dried

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    collaborator OTHER

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Sidero Bioscience, LLC

    lead INDUSTRY

Principal Investigators

  • Darren Wolfe, PhD · Sidero Bioscience, LLC

  • James R Connor, PhD · Milton S. Hershey Medical Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-17
Primary Completion
2019-03-31
Completion
2020-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03484026 on ClinicalTrials.gov